ELDN (Eledon Pharmaceuticals Inc.) Net Profit

ELDN (Eledon Pharmaceuticals, Inc.) - company brandmark

This daily price chart for Eledon Pharmaceuticals (ELDN) reflects metrics at the level of -0.10. The business focuses on developing transplantation therapies, which ensures stability in the US due to the humanitarian status of its research. Eledon Pharmaceuticals (ELDN) operates as a flexible research hub, outsourcing drug manufacturing and testing to third-party contractors, thereby eliminating the costs of maintaining its own production facilities.

ELDN (Eledon Pharmaceuticals) Net Profit history from 07/04/2022 to 10/31/2026

Analytical breakdowns and data insights for company Eledon Pharmaceuticals, Inc. (ELDN)

- price and consensus price forecast:
Stock Quotes Eledon Pharmaceuticals, Inc|ELDN - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Eledon Pharmaceuticals, Inc|ELDN - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Eledon Pharmaceuticals|ELDN - Book Capitalization|Market Capitalization to Book Value eledon.com|ELDN - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Eledon Pharmaceuticals|ELDN - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Eledon Pharmaceuticals Inc.|ELDN - Company Total Debt|Debts to Book Capitalization Eledon Pharmaceuticals, Inc|ELDN - Company Long-Term Debt|Company Short-Term Indebtedness Eledon Pharmaceuticals|Immediate Liquidity eledon.com
- net income and valuation multiples indicators:
ELDN - Net Profit
Summary company analysis:Eledon Pharmaceuticals
Core merchandise of Eledon

Fundamental metrics allow for an objective assessment of capital freeze risks within the biotechnology sector. For Eledon Pharmaceuticals (ELDN), the monetization of antibody developments for transplantation via insurance reimbursements is critically important. An analysis of the company's net balance reflects the daily equity value of profit by comparing market quotes with financial statements. This indicator measures the business's real financial health without time lags. The trend of this metric helps investors determine the balance between current expenditures and growth potential.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|Company Net Income Pharming Corp|Nektar Therapeutics (NKTR) - Company Net Income|UPB (upstreambio.com) - Company Net Income|ZBIO (Zenas Biopharma) - Net Profit|Company Net Income Immunome Inc IMNM|Net Profit GOSS|KalVista Corp - Company Profit|Company Net Income Septerna Inc SEPN|pieris.com (PVLA) - Company Net Income|SVRA - Company Net Income|RIGL (Rigel Pharma) - Company Profit|ANAB (AnaptysBio Corp) - Net Income|Astria Corp - Final Profit|Company Net Income enGene Holdings Inc.|rapt.com - Profit After Tax|Net Profit JBIO|ACRS (Aclaris Therapeutics Inc.) - Final Profit|Net Profit KYTX (Kyverna)|Net Profit Tiziana Life Sciences, Ltd. TLSA|CABA - Company Net Income|Final Profit VTYX (ventyxbio.com)|Theratechnologies (THTX) - Company Net Income|Net Income Avalo Therapeutics, Inc.|AGEN (Agenus Inc) - Net Profit|Net Profit Climb Bio, Inc|Net Profit ZURA|Net Income atyrpharma.com ATYR|Net Profit ADAG (Adagene Inc.)|ImageneBio (IMA) - Company Net Income|STTK: Net Income|EQ - Net Profit|CNTB (connectbiopharm.com) - Net Income|IMUX: Profit After Payment of Taxes|ATRA (Atara Biotherapeutics, Inc.) - Net Profit|InflaRx GmbH (IFRX) - Net Financial Result|Net Profit XFOR|Net Income adicetbio.com ACET|Net Profit CELU (Celularity)|Net Profit inmunebio.com INMB|BRNS - Company Net Income|KZR: Company Net Income|SAB Biotherapeutics, Inc (SABS) - Company Net Income|AKTX - Net Financial Result|ENLV (Enlivex Therapeutics Ltd) - Net Profit|Company Net Income Q32 Bio Corp QTTB|Company Net Income GeoVax (GOVX)|Company Net Income EDSA (Edesa Biotech Inc)|Net Profit IBIO (iBio Corp)|CARM: Company Profit|XTLB - Company Net Income|BOLT (Bolt Biotherapeutics) - Company Profit|hcwbiologics.com (HCWB) - Company Net Income|Profit After Tax APVO (Aptevo Therapeutics Inc.)|AIM (AIM ImmunoTech) - Net Profit|ADTX: Final Profit|Net Profit GRI|Net Profit xortx.com (XRTX)|Company Net Income Vyome Holdings HIND|Final Profit REVB|INDP - Company Net Income|BiondVax Pharmaceuticals (SCNI) - Net Income|CALI: Net Profit|Affimed N.V. (AFMD) - Net Profit|Net Income ALLK|HOOK: Final Profit|Net Profit IGMS|Net Financial Result iTeos Pharma|Company Net Income Ocean Biomedical, Inc. OCEA|TCBP - Net Income|THRD - Company Net Income